ACST
Acasti Pharma Inc.
2.90
-
0.06
2.03%
0 x 0.00
0 x 0.00
bid
ask
0 @ 04:00 PM
2.93+0.03 (1.03%)
Bearish
25
Bullish
84
sentiment
2.77
day range
3.04
1.77
52 week range
3.72
Prev Close2.96
Open2.80
Low2.77
High3.04
Volume3.82K
Avg. Volume25.97K
Market Cap27.26M
Inst. Own12.13%
Beta1.52
Short Ratio0.12
Div & Yield0.00 /
EPS-5.68
P/E0.00
1yr Target6.00
50day MA3.30
200day MA2.60
CNQ.TO
Canadian Natural Resources Limited
106.52
04:00 PM
+
0.84
0.79%
G.TO
Augusta Gold Corp.
0.96
03:59 PM
-
0.07
6.80%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.25
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2533.05
05:59 AM
-
46.55
1.80%
600690.SS
Haier Smart Home Co., Ltd.
28.35
03:00 AM
-
0.08
0.28%
0700.HK
Tencent Holdings Limited
348.40
04:08 AM
+
9.00
2.65%
1101.TW
Taiwan Cement Corp.
31.80
01:30 AM
-
0.20
0.62%
20MICRONS.NS
20 Microns Limited
162.85
05:59 AM
+
5.90
3.76%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024 | globenewswire.com • |
Acasti to Participate in the H.C. Wainwright Global Investment Conference | globenewswire.com • |
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting | globenewswire.com • |
Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? | zacks.com • |
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript | seekingalpha.com • |
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31 | globenewswire.com • |
Profile
...
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-02-12 | 2023-12 | -0.3 | -0.21 | 0.09 | 30.00% |
2023-11-13 | 2023-09 | -0.29 | -0.19 | 0.1 | 34.48% |
2023-08-11 | 2023-06 | -0.63 | -0.34 | 0.29 | 46.03% |
2023-06-23 | 2023-03 | -0.78 | -0.3 | 0.48 | 61.54% |
2023-02-14 | 2022-12 | -0.78 | -0.54 | 0.24 | 30.77% |
2022-11-14 | 2022-09 | 0 | -0.66 | N/A | N/A |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-09-08 | Kohli (Prashant) | Senior Officer of Issuer | 128.14K | Opening Balance-Initial SEDI Report |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Renaissance Technologies, LLC | 11.27K | 35.50K | 0.15% |
2023-06-29 | Geode Capital Management, LLC | 3.06K | 9.63K | 0.04% |
2023-09-29 | National Bank of Canada/FI | 2.90K | 8.07K | 0.04% |
2023-06-29 | Jane Street Group, LLC | 2.37K | 7.46K | 0.03% |
2023-06-29 | Morgan Stanley | 1.88K | 5.93K | 0.03% |
2023-06-29 | Two Sigma Securities, LLC | 2.52K | 7.92K | 0.03% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 3.06K | 9.91K | 0.04% |
Split
...
Split | Date |
---|---|
1 : 6 | 2023-07-10 |
1 : 8 | 2021-08-31 |
1 : 10 | 2015-10-15 |
1 : 10 | 2015-10-14 |
This topic has been deleted. Only users with topic management privileges can see it.
-
Trubach/Putin - you did not receive a response from management because I had them block your email.
-
Market is down 1% but this POS is down 8%? WTHELL???
-
Iran or bad news? Did they pump so they can short knowing bad news is coming?
-
Trubach/Putin moron. Just stop posting
-
Hey Trubach/Putin douchebag. I still see your posts on My Stock Master app.
-
-
Acasti to Participate in the H.C. Wainwright Global Investment Conference
globenewswire.com • -
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
globenewswire.com • -
Best Penny Stocks To Buy Now? 4 Stocks Under $4 To Watch
pennystocks.com • -
Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript
seekingalpha.com • -
Acasti Pharma to Present at Q4 Investor Summit
globenewswire.com • -
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
globenewswire.com • -
Penny Stocks To Buy Now? 6 To Watch Under $1 This Week
pennystocks.com • -
New Strong Sell Stocks for February 23rd
zacks.com • -
Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference
globenewswire.com • -
Acasti Pharma Stock (ACST): Why The Price Surged
pulse2.com • -
ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6
investorplace.com • -
Best Penny Stocks to Watch as the Market Takes a Bullish Turn
pennystocks.com • -
See Why Acasti Pharma Shares Are Trading Over 20% Higher?
benzinga.com • -
Acasti Pharma To Present At The Q4 Investor Summit on November 16th
newsfilecorp.com • -
Why Shares of Acasti Pharma Slumped Tuesday
fool.com • -
Are These Penny Stocks on Your Watchlist Right Now?
pennystocks.com • -
Best Penny Stocks to Buy in August? 4 for Your Watchlist
pennystocks.com • -
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
pennystocks.com • -
5 Hot Penny Stocks You Need to Know About in 2021
pennystocks.com • -
Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist
pennystocks.com • -
What Penny Stocks to Buy Today? 7 Small-Caps to Watch Right Now
pennystocks.com • -
Reddit Penny Stocks to Buy? 7 You Need to Know About In July
pennystocks.com • -
Acasti Pharma reduces losses as it progresses Grace Therapeutics transaction
proactiveinvestors.com • -
Biotech Penny Stocks Pushing Up During The Crypto Crash, One Up 25%
pennystocks.com • -
ACST Stock: Over 4% Increase Pre-Market Explanation
pulse2.com • -
Acasti Pharma Falls To Support, Stages Huge Rebound
benzinga.com • -
3 Penny Stocks That Investors Need to Watch In 2021
pennystocks.com • -
ACST Stock: Over 10% Increase Pre-Market Explanation
pulse2.com • -
Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc.
globenewswire.com • -
Best Penny Stocks to Buy Under $2? Check These 3 Out
pennystocks.com • -
Acasti Pharma Stock Is Only Ideal for a Short-Term Trade
investorplace.com • -
Acasti Pharma Provides Update on Recent Financing Activities
globenewswire.com • -
Acasti Pharma awaiting business review outcome after CaPre drug trial disappointment
proactiveinvestors.com • -
Acasti Pharma posts fiscal third quarter results as strategic review continues
proactiveinvestors.com • -
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
globenewswire.com • -
Acasti Pharma Provides Update on Recent Financing Activities
globenewswire.com • -
Acasti Pharma Unaware of Any Material Change
globenewswire.com • -
ACST Stock: 13 Things to Know as Acasti Pharma Shares Soar 100%
investorplace.com • -
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
globenewswire.com • -
What Makes Acasti (ACST) a New Buy Stock
finance.yahoo.com • -
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
finance.yahoo.com • -
Why Acasti Pharma's Stock Is Trading Higher Today
finance.yahoo.com • -
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
finance.yahoo.com • -
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
finance.yahoo.com • -
Hedge Funds Souring On Acasti Pharma Inc. (ACST)
finance.yahoo.com • -
28 Stocks Moving in Tuesday's Pre-Market Session
benzinga.com • -
Does The Acasti Pharma Inc. (CVE:ACST) Share Price Fall With The Market?
finance.yahoo.com • -
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
finance.yahoo.com • -
Oppenheimer Thinks Acasti Pharma's Stock is Going to Recover
smarteranalyst.com • -
10 Biotech Winners And Losers In Q1
benzinga.com • -
Stocks That Hit 52-Week Lows On Thursday
benzinga.com •